Product Information
HYDRALAZINE 100 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0717 per EA under NDC 76282031201. Its NADAC has been published 526 times since Sep 7, 2016.
FDA first approved this application on Dec 15, 2008.
Strength
100 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282031201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090255FDA Approved
12/15/2008
On Market Since
5/20/2016
Pharmacological Classes
Price Statistics
The NADAC for HYDRALAZINE 100 MG TABLET has been published 526 times since Sep 7, 2016, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0717 per EA |
|---|---|
| All-time high | $0.1521 (Sep 14, 2016) |
| All-time low | $0.0618 (Nov 20, 2024) |
| 52-week high | $0.0792 |
| 52-week low | $0.0717 |
| Median price | $0.0901 |
| Average price | $0.0906 |
| Largest weekly change | -29.6% (Sep 21, 2016) |
| Weeks tracked | 526 |
| Tracking since | Sep 7, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HydrALAZINE Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Arteriolar Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDRALAZINE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDRALAZINE 100 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0717 per EA (NDC 76282031201), effective Sep 30, 2026.
How has the price of HYDRALAZINE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDRALAZINE 100 MG TABLET has declined 52.9%. It has been tracked across 526 weekly CMS publications since Sep 7, 2016.
What are the highest and lowest recorded NADAC prices for HYDRALAZINE 100 MG TABLET?
Since Sep 7, 2016, the NADAC for HYDRALAZINE 100 MG TABLET has ranged from a low of $0.0618 (Nov 20, 2024) to a high of $0.1521 (Sep 14, 2016), with a median of $0.0901 per EA.
Are there cheaper alternatives to HYDRALAZINE 100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as HYDRALAZINE 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDRALAZINE 100 MG TABLET?
HYDRALAZINE 100 MG TABLET (NDC 76282031201) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.